Both Semaglutide and the drug represent new strategies to treating type 2 diabetes, and increasingly, excess weight. Tirzepatide is a dual agonist that targets multiple chemicals involved in metabolism: GLP-1 and GIP. https://thingstoknowabouttirzepa882666.bloggingpiece.com/profile